Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC)
2.220
+0.080 (3.74%)
Jun 13, 2025, 4:39 PM ICT
BKK:AMARC Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Operating Revenue | 371.89 | 345.28 | 289.21 | 263.22 | 245.95 | 219.74 | Upgrade
|
Other Revenue | 3.21 | 3.81 | 4.64 | 1.04 | 2.6 | 0.45 | Upgrade
|
Revenue | 375.1 | 349.09 | 293.85 | 264.26 | 248.55 | 220.19 | Upgrade
|
Revenue Growth (YoY) | 23.04% | 18.80% | 11.20% | 6.32% | 12.88% | 11.19% | Upgrade
|
Cost of Revenue | 212.02 | 205.48 | 180.74 | 158.17 | 141.02 | 121.81 | Upgrade
|
Gross Profit | 163.08 | 143.61 | 113.11 | 106.09 | 107.53 | 98.38 | Upgrade
|
Selling, General & Admin | 105.85 | 102.23 | 97.33 | 81.98 | 73.16 | 64.74 | Upgrade
|
Operating Expenses | 105.85 | 102.23 | 97.33 | 81.98 | 73.16 | 64.74 | Upgrade
|
Operating Income | 57.23 | 41.38 | 15.78 | 24.12 | 34.37 | 33.64 | Upgrade
|
Interest Expense | -1.56 | -1.82 | -2.83 | -6.17 | -6.89 | -4.53 | Upgrade
|
Earnings From Equity Investments | - | - | -0.33 | - | - | - | Upgrade
|
Pretax Income | 55.67 | 39.56 | 12.61 | 17.94 | 27.48 | 29.11 | Upgrade
|
Income Tax Expense | -1.44 | -0.34 | 2.97 | 3.43 | 2.62 | 0.68 | Upgrade
|
Net Income | 57.11 | 39.9 | 9.64 | 14.52 | 24.86 | 28.43 | Upgrade
|
Net Income to Common | 57.11 | 39.9 | 9.64 | 14.52 | 24.86 | 28.43 | Upgrade
|
Net Income Growth | 286.32% | 313.70% | -33.56% | -41.62% | -12.53% | 56.27% | Upgrade
|
Shares Outstanding (Basic) | 420 | 420 | 420 | 327 | 300 | 300 | Upgrade
|
Shares Outstanding (Diluted) | 420 | 420 | 420 | 327 | 300 | 300 | Upgrade
|
Shares Change (YoY) | - | - | 28.46% | 8.99% | - | 44.08% | Upgrade
|
EPS (Basic) | 0.14 | 0.09 | 0.02 | 0.04 | 0.08 | 0.09 | Upgrade
|
EPS (Diluted) | 0.14 | 0.09 | 0.02 | 0.04 | 0.08 | 0.09 | Upgrade
|
EPS Growth | 286.32% | 313.71% | -48.28% | -46.43% | -12.53% | 8.46% | Upgrade
|
Free Cash Flow | 60.6 | 57.66 | -12.59 | 32.75 | 54.38 | -114.89 | Upgrade
|
Free Cash Flow Per Share | 0.14 | 0.14 | -0.03 | 0.10 | 0.18 | -0.38 | Upgrade
|
Dividend Per Share | 0.060 | 0.060 | 0.039 | 0.100 | 0.050 | 0.025 | Upgrade
|
Dividend Growth | 53.85% | 53.85% | -61.00% | 100.00% | 100.00% | 25.00% | Upgrade
|
Gross Margin | 43.48% | 41.14% | 38.49% | 40.15% | 43.26% | 44.68% | Upgrade
|
Operating Margin | 15.26% | 11.85% | 5.37% | 9.13% | 13.83% | 15.28% | Upgrade
|
Profit Margin | 15.23% | 11.43% | 3.28% | 5.49% | 10.00% | 12.91% | Upgrade
|
Free Cash Flow Margin | 16.16% | 16.52% | -4.29% | 12.39% | 21.88% | -52.18% | Upgrade
|
EBITDA | 90.71 | 75.82 | 20.45 | 53.3 | 58.99 | 51.92 | Upgrade
|
EBITDA Margin | 24.18% | 21.72% | 6.96% | 20.17% | 23.73% | 23.58% | Upgrade
|
D&A For EBITDA | 33.48 | 34.44 | 4.67 | 29.18 | 24.61 | 18.28 | Upgrade
|
EBIT | 57.23 | 41.38 | 15.78 | 24.12 | 34.37 | 33.64 | Upgrade
|
EBIT Margin | 15.26% | 11.85% | 5.37% | 9.13% | 13.83% | 15.28% | Upgrade
|
Effective Tax Rate | - | - | 23.54% | 19.11% | 9.52% | 2.35% | Upgrade
|
Revenue as Reported | 375.1 | 349.09 | 293.85 | 264.26 | 248.55 | 220.19 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.